Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Fulcrum Therapeutics Inc
About FULC
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological disorders. The Company's lead clinical program is pociredir, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease (SCD). It uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of genetically defined diseases. In addition to its product candidates, the Company has developed a discovery approach to systematically identify and validate cellular drug targets that can potentially modulate gene expression to treat known root causes of genetically defined rare diseases. It also presented preclinical data for FTX-6274, an oral EED inhibitor candidate, demonstrating tumor growth inhibition in castration resistant prostate cancer models.
Find out what a historical investment in Fulcrum Therapeutics Inc would be worth today using our FULC stock calculator.
Market Capitalisation
$241.21M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
10.88K
High today
$3.78
Low today
$3.58
Open price
$0.00
52-week high
$15.74
52-week low
$2.83
Ready to start your investing journey with Stake?
Open an accountHow do I buy FULC shares in Australia?
Buying FULC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Fulcrum Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FULC
What is the ticker symbol of Fulcrum Therapeutics Inc?
The ticker symbol for Fulcrum Therapeutics Inc is FULC.
How much is one share of FULC?
One share of FULC is valued at $3.64 as of 21 July 2026.
What is the market capitalisation of Fulcrum Therapeutics Inc FULC?
As of 21 July 2026 Fulcrum Therapeutics Inc has a market cap of $241.21M.
What is the 52-week high for Fulcrum Therapeutics Inc stock?
The Fulcrum Therapeutics Inc 52-week high stock price is $15.74.
What is the 52-week low for Fulcrum Therapeutics Inc stock?
The Fulcrum Therapeutics Inc 52-week low stock price is $2.83.
Can I buy FULC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FULC shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FULC on Stake
- Buy FULC from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FULC from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FULC related stocks